DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Morclofone
Morclofone
TARIFF SCHEDULE of CHILE Description MFN Base Rate
(12) Patent Application Publication (10) Pub. No.: US 2004/0224012 A1 Suvanprakorn Et Al
(12) United States Patent (10) Patent No.: US 9,314.465 B2 Brew Et Al
UNIVERSITE DE NANTES Thomas Gelineau
General Pharmacology
Pharmaceutical Appendix to the Tariff Schedule 2
Free Trade Agreement Between Hong Kong, China and Chile ;
Alphabetical Listing of ATC Drugs & Codes
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
1564 Cough Suppressants Expectorants Mucolytics and Nasal Decongestants
Wo 2008/127291 A2
123 Annex 1 Referred to in Chapter 3 Schedules in Relation To
The Effect of Butamirate Versus Dextromethorphan Was Studied in Patients with Irritable Cough
Florencio Zaragoza Dörwald Lead Optimization for Medicinal Chemists
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Customs Tariff - Schedule
A Pharmaceutical Composition Comprising a Menthane Carboxylic Acid Amide
Top View
19 May 2011 (19.05.2011) 1 a Z
Customs Tariff - Schedule Xxi - 1
Australian Statistics on Medicines 2009
WO 2013/021199 A2 14 February 2013 (14.02.2013) P O P C T
Method for Producing Monolithic Tablets
(4) Australia-Chile
Estta517331 01/22/2013 in the United States Patent And
Management of Cough
WO 2U11/132171 Al
(12) United States Patent (10) Patent No.: US 8,632,805 B2 Naringrekar Et Al
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
(19) United States (12) Patent Application Publication (10) Pub
(12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
Texte De La Thèse
MFN Applied Tariff Rates 2010 17Mayo2010
Identification of Applicable 6-Digit HS Subheadings for Products Covered by the Proposed Uruguay Round Pharmaceutical Agreement
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Pharmaceutical Compositions Resistant to Abuse
Cough Management